Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958253 · ClinicalTrials.gov registry record · NA
Lung Cancer Screening Protocol
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT03958253 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 193 participants.
The verdict
NCT03958253, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.
Interventions
- OTHER Toolbox for Lung Cancer Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2019-04-22 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03958253
The ClinicalTrials.gov registry entry for NCT03958253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Toolbox for Lung Cancer Screening is the first listed.
NCT03958253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03958253 about?
NCT03958253 is a clinical study titled "Lung Cancer Screening Protocol". The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and impl...
What is the current status of trial NCT03958253?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2019-04-22. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03958253?
The interventions under investigation include: Toolbox for Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT03958253?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.